You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
The story of the commercialization of biology by a pioneer in biotechnology patenting Shortly after the emergence of genetic engineering in the 1970s, academic biologists were courted by venture capitalists and multinational companies. Researchers who understood the new biology of the time went from being merely curious about how the natural world functioned to realizing that they could profit from their newfound recognition. As they were inventing all sorts of newfangled organisms, biologists became acquainted with intellectual property. Patenting Life provides insights into legal fights over patented microbes, virus-resistant crops, ownership of body parts, and the patents they engendered....
The cost of patent licenses needed to design a new genetic test or treatment may ultimately prevent research projects getting started, as individual components are protected by different patent owners. This book examines legal measures which might be used to solve the problem of fragmentation of patents in genetics.
Though a US-China conflict is far from inevitable, major tensions are building in the Asia-Pacific region. These strains are the result of historical enmity, cultural divergence, and deep ideological estrangement, not to mention apprehensions fueled by geopolitical competition and the closely related “security dilemma.” Despite worrying signs of intensifying rivalry, few observers have provided concrete paradigms to lead this troubled relationship away from disaster. This book is dramatically different in that Lyle J. Goldstein’s focus is on laying bare both US and Chinese perceptions of where their interests clash and proposing new paths to ease bilateral tensions through compromise. ...
This report addresses a topic of recognized policy concern. To capture the benefits of substantial U.S. investments in biomedical R&D, parallel investments in a wide range of seemingly unrelated disciplines are also required. This report summarizes a major conference that reviewed our nation's R&D support for biotechnology and information technologies. The volume includes newly commissioned research and makes recommendations and findings concerning the important relationship between information technologies and biotechnology. It emphasizes the fall off in R&D investments needed to sustain the growth of the U.S. economy and to capitalize on the growing investment in biomedicine. It also encourages greater support for inter-disciplinary training to support new areas such as bioinformatics and urges more emphasis on and support for multi-disciplinary research centers.